G. Bauman, Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.4, pp.923-929, 1999.
DOI : 10.1016/S0360-3016(99)00284-9

G. Kaloshi, Chimiothérapie des gliomes diffus de bas grade, Lettre du Neurologue, pp.118-120, 2008.

. Smith, Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas, Journal of Clinical Oncology, vol.18, issue.3, pp.636-681, 2000.
DOI : 10.1200/JCO.2000.18.3.636

Y. Okamoto, Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas, Acta Neuropathologica, vol.108, issue.1, pp.44-56, 2004.
DOI : 10.1007/s00401-004-0861-z

. Hamlat, Oligodendroglioma: clinical study and survival analysis correlated with chromosomal anomalies, Neurosurgical Focus, vol.61, issue.5, p.15, 2005.
DOI : 10.1016/S0360-3016(02)03053-5

. Perry, Ancillary fish analysis for 1p and 19q status preliminary observations in 287 gliomas and oligodendroglioma mimics, Frontiers in Bioscience, vol.8, issue.1, pp.1-9, 2003.
DOI : 10.2741/896

M. Kujas, Classification anatomo-pathologique des gliomes, Lettre du neurologue n°1, 2007.

T. Watanabe, Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas, Acta Neuropathologica, vol.103, issue.3, pp.267-275, 2002.
DOI : 10.1007/s004010100464

. Ohgaki, Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas, Journal of Neuropathology & Experimental Neurology, vol.10, issue.6, pp.479-489, 2005.
DOI : 10.1093/carcin/16.6.1277

C. Houiller, Impact pronostic des mutations IDH1 et IDH2 dans les gliomes de bas grade, Résumé JNLF, 2011.

M. Labussiere, All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2, Neurology, vol.74, issue.23, pp.1886-1890, 2010.
DOI : 10.1212/WNL.0b013e3181e1cf3a

R. Kortmann, Sofortige postoperative Strahlentherapie oder abwartende Haltung bei der Behandlung niedrigmaligner Gliome im Erwachsenenalter?, Strahlentherapie und Onkologie, vol.180, issue.7, pp.408-418, 2004.
DOI : 10.1007/s00066-004-1221-6

D. Vital and D. , Guide pratique des médicaments-Dorosz : lomustine, 2010.

M. Peyre, Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas, Neuro-Oncology, vol.24, issue.18, pp.1078-1082, 2010.
DOI : 10.1200/JCO.2005.04.6078

M. Klein, Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study, The Lancet, vol.360, issue.9343, pp.1361-68, 2002.
DOI : 10.1016/S0140-6736(02)11398-5

. Postma and . Tj, Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma, pp.69-75, 1998.

J. Vesper, Retrospective analysis of treatment outcome in 315 patients with oligodendroglial brain tumors, BMC Neurology, vol.31, issue.1, p.33, 2009.
DOI : 10.1053/j.seminoncol.2004.07.006

H. Catenoix, Effets ?? long terme de la chimioth??rapie chez 7 patients pr??sentant un gliome de bas grade symptomatique, Revue Neurologique, vol.162, issue.11, pp.1069-75, 2006.
DOI : 10.1016/S0035-3787(06)75119-0

. Mason and . Wp, Low-grade oligodendroglioma responds to chemotherapy, Neurology, vol.46, issue.1, 1996.
DOI : 10.1212/WNL.46.1.203

E. Stege, Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine, Cancer, vol.52, issue.4, pp.802-809, 2005.
DOI : 10.1016/S0167-8140(96)91782-X

J. Buckner, Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities, Journal of Clinical Oncology, vol.21, issue.2, pp.251-255
DOI : 10.1200/JCO.2003.06.023

). Evs, . Nci, and . Nih, (s. d.) Common Terminology Criteria for Adverse Events (CTCAE) EVS - National Institutes of Health

. Macdonald and . Dr, Successful chemotherapy for newly diagnosed aggressive oligodendroglioma, Annals of Neurology, vol.59, issue.5, pp.573-574, 1990.
DOI : 10.1002/ana.410270519

N. Paleologos, Chemotherapy for low-grade oligodendroglioma?, 1994.

R. Soffietti, PCV Chemotherapy for Recurrent Oligodendrogliomas and Oligoastrocytomas, Neurosurgery, vol.68, issue.5, pp.1066-1073, 1998.
DOI : 10.3171/jns.1988.68.5.0684

. Van, . Bent, and . Mj, Response rate and prognostics factors of recurrent oligodendroglioma treated with procarbazine, CCNU and vincristine chemotherapy, Neurooncology group, vol.51, issue.53, pp.1140-1145, 1998.

J. Streffer, A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors, Journal of Neurology, vol.247, issue.4, pp.297-302, 2000.
DOI : 10.1007/s004150050587

C. Lebrun, Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults, Revue Neuro, issue.160, pp.533-537, 2004.

. Ty and . Au, Oligodendroglial tumor chemotherapy using "decreased-dose-intensity, 2006.
DOI : 10.1212/01.wnl.0000194211.68164.a0

C. Lebrun, Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy, European Journal of Neurology, vol.63, issue.4, pp.391-399, 2007.
DOI : 10.1002/cncr.20042

). Anesm and . Mainio, La qualité de vie en établissement d'hébergement pour personnes âgées dépendantes (Ehpad) Consulté le 22 Juin 2013 sur http Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow, Eur Arch Psychiatry Clin Neurosci, vol.256, issue.58, pp.516-521, 1990.

M. Brada, Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma, Journal of Clinical Oncology, vol.28, issue.30, pp.4601-4609, 2010.
DOI : 10.1200/JCO.2009.27.1932

. Wick, NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide, Journal of Clinical Oncology, vol.27, issue.35, pp.275874-80, 2009.
DOI : 10.1200/JCO.2009.23.6497

. Lassman and . Ab, International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors, Neuro-Oncology, vol.74, issue.23, pp.649-59, 2011.
DOI : 10.1212/WNL.0b013e3181e1cf3a

R. Liu, Quality of life in low-grade glioma patients receiving temozolomide, Neuro-Oncology, vol.11, issue.1, 2009.
DOI : 10.1023/A:1023900802254

L. Douw, Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up, The Lancet Neurology, vol.8, issue.9, pp.810-828, 2009.
DOI : 10.1016/S1474-4422(09)70204-2

F. Bonnetblanc, Gliomes de bas grade et plasticit?? c??r??brale, m??decine/sciences, vol.22, issue.4, pp.389-394, 2006.
DOI : 10.1051/medsci/2006224389

URL : http://www.medecinesciences.org/articles/medsci/pdf/2006/05/medsci2006224p389.pdf